論文(2020)
著書
1 荒金尚子：解説 血漿遊離 DNA を用いた liquid biopsy．腫瘍内科 特集：期待される新規薬剤，分子標的治療・免疫療法の耐性機序とその克服，25（5），582‐588．科学評論社 2020，5．
2 荒金尚子：総説 肺癌における liquid biopsy の意義／Invited Review Articles Significance of a Liquid Biopsy on Lung Cancer．肺癌／Haigan，60（2），67‐73．日本肺癌学会 2020，4．
3 草場香那，渡邊慶介：がん免疫における新規治療アプローチ 1）CAR-T 細胞療法の進展と課題．腫瘍内科 特集：がん免疫療法におけるバイオマーカーと新規治療アプローチ，26（1），63‐70．科学評論社 2020，7．
4 Sueoka-Aragane N: Review article Current achievements and future perspectives with liquid biopsy.Personalized Medicine Universe, Vol. 9, 3-9．国際個別化医療学会 2020，10．
5 髙橋浩一郎：物理アレルギー．今日の治療指針 2020年版，13．アレルギー疾患，856‐857．医学書院 2020，1．
6 髙橋浩一郎，矢寺和博：重症喘息の bio 製剤の使い方 重症喘息に対する bio 製剤は症例の特徴（フェノタイプ）を見きわめて使用する（Q&A）．週刊日本医事新報（2020年02月29日）No．5001，p53．日本医事新報社 2020，2．
7 田代宏樹，髙橋浩一郎：Clinical Academic Topics 肥満難治性喘息の制御：腸内細菌叢の役割．アレルギーの臨床 特集：喘息診療で注目されるバイオマーカー（Attractive biomarkers in asthma practice），40（7），598‐600．北隆館 2020，6．
8 田代宏樹，髙橋浩一郎：トピックス：呼吸器疾患の検査 up to date 閉塞性肺疾患検査のトピックス．臨床病理，68（10），817‐824．克誠堂出版 2020，11．
9 田代宏樹：【連載】〈One Point Advice〉難治性喘息治療の落とし穴．Medical Practice 今月のテーマ：糖尿病－合併症や併存症を見据えた治療戦略の最前線，37（11）．文光堂 2020，11．
10 田代宏樹，髙橋浩一郎：Clinical Academic Topics 腸内細菌叢を標的とした肥満喘息の制御．アレルギーの臨床 特集：思春期・成人のアレルギー診療～アレルギー疾患と如何につき合うか～（Allergic diseases in adolescents and adults-Points of practical management）．北隆館 2020，11．
11 嬉野博志，木村晋也：2．慢性骨髄性白血病（2）初発慢性期の慢性骨髄性白血病の治療．日本臨牀78巻 増刊号3 特集：造血器腫瘍学（第2版）－基礎と臨床の最新研究動向－，Ⅳ．骨髄系腫瘍の臨床，p316‐321．日本臨床社 2020，8．
原著論文
1 Abe T, Nakashima C, Sato A, Harada Y, Sueoka E, Kimura S, Kawaguchi A, Sueoka-Aragane N: Origin of circulating free DNA in patients with lung cancer. PLoS One, 15(7): e0235611, 2020, 7.
2 Hoshiko T, Kubota Y, Akisawa T, Watanabe T, Tanigawara K, Yano J, Kimura S: Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells. Invest New Drugs. 38(4): 1012-1019, 2020, 8.
3 Kagami Y, Yamamoto K, Shibata T, Tobinai K, Imaizumi Y, Uchida T, Shimada K, Minauchi K, Fukuhara N, Kobayashi H, Yamauchi N, Tsujimura H, Hangaishi A, Tominaga R, Suehiro Y, Yoshida S, Inoue Y, Suzuki S, Tokuhira M, Kusumoto S, Kuroda J, Yakushijin Y, Takamatsu Y, Kubota Y, No-saka K, Morishima S, Nakamura S, Ogura M, Maruyama D, Hotta T, Morishima Y, Tsukasaki K, Nagai H: R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study. Cancer Sci, 111(10): 3770-3779, 2020, 10.
4 Kanda J, Ando T, Kimura SI, Fujiwara SI, Imada K, Fujisawa S, Tachibana T, Atsuta Y, Kanda Y: Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1- Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin. Cell Transplant, Vol. 29, 963689720976567, 2020.
5 Kitamura H, Kubota Y, Komukai S, Yoshida H, Kaneko Y, Mihara Y, Nagasawa Z, Kawaguchi A, Aoki Y, Kimura S: Venue of catheter insertion does not significantly impact the event of central lineassociated bloodstream infection in patients with haematological diseases. Infection Prevention in Practice 2(2): 1-8, 2020, 6.
6 Shinya Kimura, Jun Imagawa, Kazunori Murai, Masayuki Hino, Toshio Kitawaki, Masaya Okada, Hideo Tanaka, Motohiro Shindo, Takashi Kumagai, Takayuki Ikezoe, Nobuhiko Uoshima, Tsutomu Sato, Reiko Watanabe, Shugo Kowata, Masaya Hayakawa, Takaaki Hosoki, Kazuhiko Ikeda, Tsutomu Kobayashi, Yasutaka Kakinoki, Tetsuo Nishimoto, Naoki Takezako, Hirohiko Shibayama, Akifumi Takaori-Kondo, Hirohisa Nakamae, Atsushi Kawaguchi, Hiroshi Ureshino, Junichi Sakamoto, Yoji Ishida, on behalf of the DADI Trial Group: Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a singlearm, multicentre, phase 2 trial. Lancet Haematol, 7(3): e218-e225, 2020, 3.
7 Sho Okamoto, Hiroshi Ureshino, Atsushi Kawaguchi, Motoaki Miyazono, Yuji Ikeda, and Shinya Kimura: Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors. Int J Hematol, 112(1): 41-45, 2020, 7.
8 Okamoto S, Ureshino H, Kidoguchi K, Kusaba K, Kizuka-Sano H, Sano H, Nishioka A, Yamaguchi K, Kamachi K, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kawaguchi A, Sueoka E, Kimura S: Clinical impact of the CONUT score in patients with multiple myeloma. Ann Hematol, 99(1): 113-119, 2020, 1.
9 Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, and Shinya Kimura: HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia. Mol Cancer Ther, 20(1): 142-149, 2021, 1.
10 Osgood RS, Tashiro H, Kasahara DI, Yeliseyev V, Bry L, Shore SA: Gut microbiota from androgenaltered donors alter pulmonary responses to ozone in female mice. Physiol Rep, 8(19): e14584, 2020, 10.
11 Sadamatsu H, Takahashi K, Tashiro H, Kurihara Y, Kato G, Uchida M, Noguchi Y, Kurata K, Ōmura S, Sunazuka T, Kimura S, Sueoka-Aragane N: The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma. Int Arch Allergy Immunol, 181(9): 665-674, 2020.
12 Sadamatsu H, Takahashi K, Tashiro H, Kato G, Noguchi Y, Kurata K, Omura S, Kimura S, Sunazuka T, Sueoka-Aragane N: The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model. Inflamm Res, 69(1): 139-151,2020, 1.
13 Sogawa R, Nakashima C, Nakamura T, Takeuchi K, Kimura S, Komiya K, Narisawa Y, Kimura S, Sueoka-Aragane N: Association of genetic polymorphisms with afatinib-induced diarrhea. In Vivo, 34(3): 1415-1419, 2020.
14 Kenta Takahashi, Eri Ishibashi, Toshio Kubo, Yohei Harada, Hideyuki Hayashi, Masayuki Kano, Yasushi Shimizu, Hidekazu Shirota, Yukiko Mori, Manabu Muto, Chikashi Ishioka, Hirotoshi DosakaAkita, Hisahiro Matsubara, Hiroshi Nishihara, Naoko Sueoka-Aragane, Shinichi Toyooka, Akihiro Hirakawa, Ukihide Tateishi, Satoshi Miyake, Sadakatsu Ikeda: A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial). Medicine (Baltimore), 99(32): e21457, 2020, 8.
15 Takahashi K, Sadamatsu H, Suzuki K, Tashiro H, Kimura S, Kuratomi Y, Sueoka-Aragane N: Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma. Respir Investig, 59(1): 126-134, 2021, 1.
16 Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, SueokaAragane N, Kawayama T: First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis, Vol. 15, 2115-2126, 2020, 9.
17 Tashiro H, Haraguchi T, Takahashi K, Sadamatsu H, Tajiri R, Takamori A, Kimura S, SueokaAragane N: Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis. BMC Pulm Med, 20(1): 116, 2020, 4.
18 Tashiro H, Kurihara Y, Takahashi K, Sadamatsu H, Haraguchi T, Tajiri R, Takamori A, Kimura S, Sueoka-Aragane N: Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med, 20(1): 318, 2020, 12.
19 Tashiro H, Takahashi K, Sadamatsu H, Kurihara Y, Haraguchi T, Tajiri R, Takamori A, Kimura S, Sueoka-Aragane N: Biomarkers for Overweight in Adult-Onset Asthma. J Asthma Allergy, Vol. 13, 409-414, 2020, 10.
20 Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Nao Yoshida, Naoko Hattori, Hideaki Nakamura, Akemi Sato, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Kensuke Kojima, Seiji Okada, Toshikazu Ushijima, Shinya Kimura, Eisaburo Sueoka: Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100. Blood, 136(7): 871-884, 2020, 8.
21 Yatabe Y, Sunami K, Goto K, Nishio K, Aragane N, Ikeda S, Inoue A, Kinoshita I, Kimura H, Sakamoto T, Satouchi M, Shimizu J, Tsuta K, Toyooka S, Nishino K, Hatanaka Y, Matsumoto S, Mikubo M, Yokose T, Dosaka-Akita H: Multiplex gene-panel testing for lung cancer patients. Pathol Int, 70(12): 921-931, 2020, 12.
22 Watanabe T, Yamashita S, Ureshino H, Kamachi K, Kurahashi Y, Fukuda-Kurahashi Y, Yoshida N, Hattori N, Nakamura H, Sato A, Kawaguchi A, Sueoka-Aragane N, Kojima K, Okada S, Ushijima T,Kimura S, Sueoka E: Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100. Blood, 136(7): 871-884, 2020, 8.
総説
1 Takaomi Kobayashi, Hiroshi Ureshino, Tadatsugu Morimoto, Chisato Shimanoe, Ko Ikuta, Motoki Sonohata, Masaaki Mawatari:〈Editorsʼ Choice〉Treatment strategy for upper cervical epidural abscess: a literature review. Nagoya J Med Sci, 83(1): 1-20, 2021, 2.
2 Shindo Takero, Ureshino Hiroshi, Kojima Hiroto, Tanaka Hidenori, Kimura Shinya: Alleric polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia. Immunol Med, 2020, 7.
3 Tashiro H, Shore SA: The Gut Microbiome and Ozone-induced Airway Hyperresponsiveness: Mechanisms and Therapeutic Prospects. Am J Respir Cell Mol Biol, 64(3): 283-291, 2021, 3.
4 Ureshino Hiroshi, Kamachi Kazuharu, Kimura Shinya: Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia. Clin Lymphoma Myeloma Leuk, 20(12): 785-790, 2020, 12. 5 Ureshino Hiroshi, Shindo Takero, Kimura Shinya: Role of Cancer Immunology in Chronic Myelogenous Leukemia. Leuk Res, Vol. 88, 106273, 2020, 1.
症例報告
1 Ando T, Sano H, Yokoo M, Kusaba K, Kidoguchi K, Yamaguchi K, Katsuya H, Yoshihara S, Kubota Y, Kojima K, Kimura S: Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor. Int J Hematol, 112(2): 249- 253, 2020, 8.
2 Katsuya H, Kizuka-Sano H, Yokoo M, Kidoguchi K, Yamaguchi K, Nishioka A, Ureshino H, Kubota Y, Ando T, Naito S, Ohshima K, Kimura S: A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation. Ann Hematol, 99(10): 2449-2451, 2020, 10.
3 Kidoguchi K, Kubota Y, Fujimoto S, SakataY, Kizuka-Sano H, Yamaguchi K, Ureshino H, Katsuya H, Ando T, Esaki M, Kimura S: Aplastic anemia in a patient with Cronkhite-Canada syndrome. Intern Med, 2020.
4 Kidoguchi K, Kubota Y, Kusaba K, Kizuka-Sano H, Yamaguchi K, Nishioka A, Yokoo M, Ando T, Kojima K, Kimura S: Severe infusion reaction, anti-rituximab antibodies and lymphoma. QJM, 113(4): 273-274, 2020, 4.
5 Keisuke Kidoguchi, Hiroo Katsuya, Hiroshi Ureshino, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Ayako Nagata, Shuichi Rikitake, Kanako Aikawa, Shinji Naito, Shigehisa Aoki, Yasushi Kubota, Toshihiko Ando, and Shinya Kimura: Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case Report. Tohoku J Exp Med, 252(2): 153-157, 2020, 10.
6 Kidoguchi K, Kubota Y, Nishimura Y, Kizuka-Sano H, Kimura S: Ibrutinib-induced cardiac tamponade in chronic lymphocytic leukemia. Turk J Haematol, 38(1): 83-85, 2021, 2.
7 Kitamura H, Kubota Y, Tomimasu R, Hirakawa H, Inoue H, Umeguchi H, Yoshida M, Akahoshi H, Tsuruda S, Ide R, Kimura S, Miyahara M: Development of acquired hemophilia A after treatment of bronchial asthma with benralizumab. Indian J Hematol Blood Transfus, 2020, 10.
8 Kurihara Y, Tashiro H, Takahashi K, Komiya N, Sadamatsu H, Kimura S, Sueoka-Aragane N: Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan. Intern Med, 2020, 11.
9 中尾真実，山田麻里江，山田尚友，川崎誠司，中村秀明，久保田寧，木村晋也，末岡榮三朗：症例 報告 低頻度抗原 Cob に対する抗体を保有する一症例．医学検査，69（3）：445‐450，2020．
10 Sadamatsu H, Takahashi K, Tashiro H, Ogusu S, Haraguchi T, Nakashima C, Nakamura T, SueokaAragane N: A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans coinfection in lung. J Infect Chemother, 26(8): 838-842, 2020, 8.
11 Takahashi K, Sadamatsu H, Tashiro H, Uchida M, Sueoka-Aragane N: Eosinophilic granulomatous polyangiitis with IgG4 hypergammaglobulinaemia and salivary gland swelling. Respirol Case Rep, 8(4): e00552, 2020, 3.
12 Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Kimura S, Sueoka-Aragane N: Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis. Allergol Int, 70(1): 145-147, 2021, 1.
13 Umino A, Kubota Y, Honda-Yoshigai M, Okazaki T, Yoshihara Y, Wakayama K, Kawasaki S, Kusaba K, Kimura S, Sueoka E: Monitoring of tumor cells by flow cytometry permits rapid evaluation of disease progression in monomorphic epitheliotropic intestinal T-cell lymphoma. Cytometry B Clin Cytom, 2020, 12.
14 Hiroshi Ureshino, Takero Shindo, Haruhiko Sano, Yasushi Kubota, Toshihiko Ando, Keisuke Kidoguchi, Kana Kusaba, Hidekazu Itamura, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Kensuke Kojima, Hidenori Tanaka, Hiroh Saji, Koichi Ohshima, Shinya Kimura: Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation. Int J Hematol, 111(5): 733-738, 2020, 5.
15 Hiroshi Ureshino, Koichi Ohshima, Masaharu Miyahara: Multiple myeloma with G-CSF production mimicking chronic neutrophilic leukemia. eJHaem, 2021, 3.
16 Hiroshi Ureshino, Shuichi Koarada, Kazuharu Kamachi, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Toshihiko Ando, Tatsuo Ichinohe, Tomohiro Morio, Shinya Kimura: Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy. Int J Hematol, 111(6): 897-902, 2020, 6.
17 Yamaguchi K, Kubota Y, Kishimori C, Ohno H, Kidoguchi K, Kizuka-Sano H, Nishioka A, Katsuya H, Ando T, Kimura S: Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation. Ann Hematol, 99(2): 389-390, 2020, 2.
最終更新日 2022年2月8日
(C)佐賀大学医学部附属病院血液・呼吸器・腫瘍内科